CD8A and cancer: Due to the increased immunogenic death of cancer cells, more endogenous tumor antigens were produced, which activated antigen presenting cells (e.g., DCs and M1 macrophages) and CD8+ T cells, causing them to generate stronger anti‐tumor immune responses and significantly inhibit tumor growth.